Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Fredrik Liedberg, Oskar Hagberg, Sten Holmäng, Abolfazl Hosseini Aliabad, Georg Jancke, Börje Ljungberg, Per-Uno Malmström, Hanna Åberg & Staffan Jahnson. (2015) Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study. Scandinavian Journal of Urology 49:4, pages 290-295.
Read now
Read now
KARIN Jonsson & HANS Hedelin. (2013) Costs associated with long-term catheter care in nursing home patients. Scandinavian Journal of Urology 47:2, pages 113-117.
Read now
Read now
Fredrik Liedberg, Erik Holmberg, Sten Holmäng, Börje Ljungberg, Per-Uno Malmström, Wiking Månsson, Leyla Nunez, Catrin Wessman, Hans Wijkström & Staffan Jahnson. (2012) Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: A Swedish population-based survey. Scandinavian Journal of Urology and Nephrology 46:1, pages 14-18.
Read now
Read now
Per-Uno Malmström, Hans Hedelin, Yngvil Kloster Thomas, Gwilym J. Thompson, Helen Durrant & Jim Furniss. (2009) Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden. Scandinavian Journal of Urology and Nephrology 43:3, pages 192-198.
Read now
Read now
H. Barton Grossman, Arnulf Stenzl, Mark A. Moyad & Michael J. Droller. (2008) Bladder Cancer: Chemoprevention, complementary approaches and budgetary considerations. Scandinavian Journal of Urology and Nephrology 42:sup218, pages 213-233.
Read now
Read now
Ingela Berrum-Svennung, Hans Hedelin & Sten Holmäng. (2005) Costs of radical cystectomy. Scandinavian Journal of Urology and Nephrology 39:1, pages 36-41.
Read now
Read now
Articles from other publishers (42)
Zhijiang Zang, Qinghui Wu & Edmund Chiong. (2019) Blue-light cystoscopy and narrow-band imaging in bladder cancer management. Formosan Journal of Surgery 52:5, pages 155-160.
Crossref
Crossref
Krystian KaczmarekArtur LemińskiAleksandra BańcarzAlicja ZakrzewskaMarcin Słojewski. (2018) Post-Operative Infections among Patients Undergoing Radical Cystectomy at a Tertiary Center. Surgical Infections 19:4, pages 451-458.
Crossref
Crossref
Maria Frantzi, Agnieszka Latosinska, Murat Akand & Axel S. Merseburger. 2018. Integration of Omics Approaches and Systems Biology for Clinical Applications. Integration of Omics Approaches and Systems Biology for Clinical Applications
347
360
.
Joost L. Boormans & Ellen C. Zwarthoff. (2016) Limited Funds for Bladder Cancer Research and What Can We Do About It. Bladder Cancer 2:1, pages 49-51.
Crossref
Crossref
Sten Holmäng. (2016) Patients with High Grade Bladder Cancer, and Tumor-Free 3 and 6-Month Cystoscopy after bacillus Calmette-Guérin have a Good Prognosis without Further Maintenance bacillus Calmette-Guérin. Urology Practice 3:1, pages 50-54.
Crossref
Crossref
Petrişor A. Geavlete, Dragoş Georgescu, Răzvan Mulţescu, Mihai Drăguţescu, Marian Jecu & Bogdan Geavlete. 2016. Endoscopic Diagnosis and Treatment in Urinary Bladder Pathology. Endoscopic Diagnosis and Treatment in Urinary Bladder Pathology
83
203
.
Fabiano Santos, Alice Dragomir, Ahmed Sayed Zakaria, Wassim Kassouf & Armen Aprikian. (2015) Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada. BMC Health Services Research 15:1.
Crossref
Crossref
Viveka Ströck & Sten Holmäng. (2015) A Prospective Study of the Size, Number and Histopathology of New and Recurrent Bladder Tumors. Urology Practice 2:5, pages 260-264.
Crossref
Crossref
J.M. Cózar, B. Miñana, J. Palou-Redorta, R.A. Medina, F. de la Rosa-Kehrmann, F. Lozano-Palacio, M.J. Ribal-Caparrós, C. Hernández-Fernández, J.J. Castiñeiras-Fernández, M.J. Requena, J. Moreno-Sierra, J. Carballido-Rodríguez & V. Baena-González. (2015) Comparative analysis of the incidence of bladder cancer in the communities of Andalusia, Catalonia and Madrid in 2011. Actas Urológicas Españolas (English Edition) 39:7, pages 420-428.
Crossref
Crossref
J.M. Cózar, B. Miñana, J. Palou-Redorta, R.A. Medina, F. de la Rosa-Kehrmann, F. Lozano-Palacio, M.J. Ribal-Caparrós, C. Hernández-Fernández, J.J. Castiñeiras-Fernández, M.J. Requena, J. Moreno-Sierra, J. Carballido-Rodríguez & V. Baena-González. (2015) Análisis comparativo de la incidencia de cáncer de vejiga en las comunidades de Andalucía, Cataluña y Comunidad de Madrid en el año 2011. Actas Urológicas Españolas 39:7, pages 420-428.
Crossref
Crossref
Elin Andersson, Christina M. Dahmcke, Kenneth Steven, Louise K. Larsen & Per Guldberg. (2015) Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer. PLOS ONE 10:7, pages e0131889.
Crossref
Crossref
Tina Schubert, Matthew R. Danzig, Srinath Kotamarti, Rashed A. Ghandour, Danny Lascano, Byron P. Dubow, G. Joel Decastro, Mitchell C. Benson & James M. McKiernan. (2014) Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome. World Journal of Urology 33:6, pages 847-852.
Crossref
Crossref
Emad F. Sabir & Sten Holmäng. (2014) TaG1 Bladder Cancer: A Third of All Primary Tumors and 80% of All Recurrences Can Be Treated in the Office Using Local Anesthesia. Urology Practice 1:4, pages 184-188.
Crossref
Crossref
Christina Yeung, Tuan Dinh & Joseph Lee. (2014) The Health Economics of Bladder Cancer: An Updated Review of the Published Literature. PharmacoEconomics 32:11, pages 1093-1104.
Crossref
Crossref
Robert S. Svatek, Brent K. Hollenbeck, Sten Holmäng, Richard Lee, Simon P. Kim, Arnulf Stenzl & Yair Lotan. (2014) The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease. European Urology 66:2, pages 253-262.
Crossref
Crossref
Tahlita C.M. Zuiverloon, Willemien Beukers, Kirstin A. van der Keur, Annemieke J.M. Nieuweboer, Thomas Reinert, Lars Dyrskjot, Torben F. Orntoft & Ellen C. Zwarthoff. (2013) Combinations of Urinary Biomarkers for Surveillance of Patients with Incident Nonmuscle Invasive Bladder Cancer: The European FP7 UROMOL Project. Journal of Urology 189:5, pages 1945-1951.
Crossref
Crossref
Tahlita C.M. Zuiverloon, Willemien Beukers, Kirstin A. van der Keur, Jesrael R. Munoz, Chris H. Bangma, Hester F. Lingsma, Marinus J.C. Eijkemans, Jan P. Schouten & Ellen C. Zwarthoff. (2012) A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine. BJU International 109:6, pages 941-948.
Crossref
Crossref
J. Stephen Jones & William A. Larchian. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
2335
2354.e8
.
Ashish M. Kamat, Jose A. Karam, H. Barton Grossman, A. Karim Kader, Mark Munsell & Colin P. Dinney. (2011) Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity. BJU International 108:7, pages 1119-1123.
Crossref
Crossref
Tahlita C.M. Zuiverloon, Stephen S. Tjin, Martijn Busstra, Chris H. Bangma, Egbert R. Boevé & Ellen C. Zwarthoff. (2011)
Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based
FGFR3
Mutation Assay
. Journal of Urology 186:2, pages 707-712.
Crossref
Crossref
Eric Reid, Hooman Djaladat & Siamak Daneshmand. (2011) The Role of Photodocumentation in Surveillance Cystoscopy for Bladder Cancer. UroToday International Journal 04:05.
Crossref
Crossref
Satya Allaparthi & K. C. Balaji. 2011. Bladder Tumors:. Bladder Tumors:
237
252
.
Tahlita C.M. Zuiverloon, Madelon N.M. van der Aa, Theo H. van der Kwast, Ewout W. Steyerberg, Hester F. Lingsma, Chris H. Bangma & Ellen C. Zwarthoff. (2010)
Fibroblast Growth Factor Receptor 3
Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder Cancer
. Clinical Cancer Research 16:11, pages 3011-3018.
Crossref
Crossref
Bruce J. Schlomer, Richard Ho, Arthur Sagalowsky, Raheela Ashfaq & Yair Lotan. (2010) Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder. Journal of Urology 183:1, pages 62-67.
Crossref
Crossref
Eduardo Solsona. (2009) Early Single Instillation Chemotherapy Is Very Beneficial and Should Be the Standard Approach in Non–Muscle-Invasive Bladder Cancer. European Urology Supplements 8:5, pages 464-469.
Crossref
Crossref
Sten Holmäng. (2009) Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer. European Urology Supplements 8:5, pages 458-463.
Crossref
Crossref
J. Stephen Jones. 2010. Bladder Cancer. Bladder Cancer
5
18
.
Arnulf Stenzl, Joerg Hennenlotter & David Schilling. (2008) Can we still afford bladder cancer?. Current Opinion in Urology 18:5, pages 488-492.
Crossref
Crossref
A. Stenzl, D. Jocham, P. Jichlinski, K. Junker, F. König, H. van den Bergh, B. Volkmer, D. Zaak & J.E. Gschwend. (2008) Photodynamische Diagnostik im HarntraktPhotodynamic diagnostics in the urinary tract. Der Urologe 47:8, pages 982-987.
Crossref
Crossref
Dirk Zaak, Wolf F. Wieland, Christian G. Stief & Maximilian Burger. (2008) Routine Use of Photodynamic Diagnosis of Bladder Cancer: Practical and Economic Issues. European Urology Supplements 7:7, pages 536-541.
Crossref
Crossref
Stefan Denzinger & Maximilian Burger. (2008) Photodynamic diagnostics of bladder tumors. Current Urology Reports 9:2, pages 101-105.
Crossref
Crossref
Piyush K. Agarwal, Peter C. Black & Ashish M. Kamat. (2007) Considerations on the use of diagnostic markers in management of patients with bladder cancer. World Journal of Urology 26:1, pages 39-44.
Crossref
Crossref
Y. Mark Hong & Kevin R. Loughlin. (2008) Economic Impact of Tumor Markers in Bladder Cancer Surveillance. Urology 71:1, pages 131-135.
Crossref
Crossref
Ingela Berrum-Svennung, Torvald Granfors, Staffan Jahnson, Hans Boman & Sten Holmäng. (2008) A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences. Journal of Urology 179:1, pages 101-106.
Crossref
Crossref
Renzo Colombo. (2007) New Procedures are Bound to Modify Our Attitude in Facing Urologic Cancers in the Near Future: Are We Ready for a Cost-Effectiveness Analysis?. European Urology 52:1, pages 11-14.
Crossref
Crossref
Maximilian Burger, Dirk Zaak, Christian G. Stief, Thomas Filbeck, Wolf-Ferdinand Wieland, Wolfgang Roessler & Stefan Denzinger. (2007) Photodynamic Diagnostics and Noninvasive Bladder Cancer: Is It Cost-Effective in Long-Term Application? A Germany-Based Cost Analysis. European Urology 52:1, pages 142-147.
Crossref
Crossref
Chul Woong YounTaek Won KangChan ChoiSoo Bang Ryu. (2007) The Significance of Biopsy of the Erythematous Lesion at Cystoscopy. Korean Journal of Urology 48:5, pages 489.
Crossref
Crossref
Vinata B. Lokeshwar & Marie G. Selzer. (2006) Urinary bladder tumor markers. Urologic Oncology: Seminars and Original Investigations 24:6, pages 528-537.
Crossref
Crossref
Matthew Creighton & Jeffrey M. Holzbeierlein. (2006) Fluid Intake and Bladder Cancer: A Review of the Available Literature. Seminars in Preventive and Alternative Medicine 2:3, pages 141-144.
Crossref
Crossref
Ebere Akobundu, Jing Ju, Lisa Blatt & C Daniel Mullins. (2006) Cost-of-Illness Studies. PharmacoEconomics 24:9, pages 869-890.
Crossref
Crossref
Robert S. Svatek, David Lee & Yair Lotan. (2005) Correlation of office-based cystoscopy and cytology with histologic diagnosis: How good is the reference standard?. Urology 66:1, pages 65-68.
Crossref
Crossref
Vijay K. Sangar, Narasimhan Ragavan, Shyam S. Matanhelia, Mike W. Watson & Rosie A. Blades. (2005) The economic consequences of prostate and bladder cancer in the UK. BJU International 95:1, pages 59-63.
Crossref
Crossref